Precigen, Inc. · NASDAQ:PGEN

Precigen — Intrexon — Corporate Update (May 2016)

9 slides from Precigen's corporate update, May 4, 2016

  1. Slide 1: Intrexon Crop Protection

    Intrexon Crop Protection May 4, 2016 Exhibit 99.2

  2. Slide 2: Safe Harbor Statement

    Safe Harbor Safe Harbor Statement Some of the statements made in this presentation are forward-looking statements that involve a number of risks and uncertainties and are made pursuant to the Safe harbor Provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statem

  3. Slide 3: Overview of Intrexon Crop Protection (ICP)

    Intrexon Crop Protection (“ICP”) provides new and effective solutions for biological control of agricultural pests by employing a multifaceted approach that includes the Oxitec and ActoBiotics® platforms Oxitec’s diverse self-limiting gene platform Pipeline of 6 self-limiting insect targets in devel

  4. Slide 4: Strategic Business Rationale

    As a stand-alone business, ICP is focused on the discovery, development and commercialization of targeted biological crop protection solutions, allowing ICP to: Establish itself as a biological crop protection solution company and emerging leader in the field Align product candidates under a single

  5. Slide 5: Large Opportunities in Agricultural Insect and Fungal Control

    While the crop protection market continues to grow at more than 5% annually, current conventional insecticides and fungicides are losing value due to increased pest resistance and off-target environmental effects Large Opportunities in Agricultural Insect and Fungal Control > $20 Billion Spent Annua

  6. Slide 6: ICP's Demonstrated Self-Limiting Insect Technology

    ICP’s Demonstrated Self-Limiting Insect Technology Successful published field trials in USA and Morocco, including data in Bt-resistant Diamondback Moth and Medfly 10+ years of platform development Self-limiting platform prevents offspring from developing into reproductive adults, resulting in popul

  7. Slide 7: ICP's Current Self-Limiting Insect Pipeline

    Products Crop R&D Phase I trial (Efficacy/ safety) Phase II trial (Efficacy) Pilot commercial trial Registration Medfly Hard Fruit Diamondback Moth Brassica Pink Bollworm Cotton D. Suzukii Soft Fruit Olive Fly Olives Confidential Target ICP’s Current Self-Limiting Insect Pipeline Morocco Australia/B

  8. Slide 8: Intrexon's ActoBiotics Platform

    Intrexon’s ActoBiotics® Platform Intrexon’s ActoBiotics® platform enables a novel approach to targeted pest control ActoBiotics® platform utilizes Lactococcus lactis, an eco-friendly GRAS microbe that demonstrates the ability to uniquely deliver active molecules such as peptides and nucleic acids IC

  9. Slide 9: ICP Team and Facility

    ICP Team and Facility The ICP team is led by President Sekhar Boddupalli and a group of experienced colleagues with a track record of success President Sekhar Boddupalli 20+ years of R&D experience in biotechnology, consumer products, and drug discovery 24 peer reviewed publications and 35 patents F

Intrexon — Corporate Update (May 2016) on 6ix